GL1X · GenesisL1 explorer

MolNFT v2 · #129910 · protein

Crystal form 2 of Alpha1-antichymotrypsin variant DBS-II-allo: an allosterically modulated drug-binding serpin for doxorubicin

5OM8 · Alpha-1-antichymotrypsin: “Crystal form 2 of Alpha1-antichymotrypsin variant DBS-II-allo: an allosterically modulated drug-binding…”. X-ray diffraction at 2.2, 2 ligands (NI, CL), 2 pockets (best druggability 0.49). MolNFT v2…

PDB
5OM8
Type
protein
Length
369 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.2
Source
Homo sapiens
Molecule
Alpha-1-antichymotrypsin
UniProt
P01011
Ligands
NI, CL
Pockets
2 · best druggability 0.49

Structure

x-ray diffraction · resolution 2.2 · 2 distinct chains · 31% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-1-antichymotrypsinprotein33634% helix, 36% strandP01011
BAlpha-1-antichymotrypsinprotein330% helix, 52% strandP01011

Ligands and binding sites

  • NI · Nickel (II) ion · metal · chains A
  • CL · Chloride ion · ion · chains A, B
  • EDO · 1,2-ethanediol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1770.490.8327empty
2800.390.7818empty

Interfaces

1 interface between chains.

  • A–B · 2534 Ų buried · 40 hydrogen bonds · protein-protein

Compared structures

  • 5OM8 · Crystal form 2 of ALPHA1-antichymotrypsin variant dbs-II-allo: an allosterically… · the same entry in another collection · chain A against A, TM-score 1.00
  • P01011 · AlphaFold monomer V2.0 prediction for alpha-1-antichymotrypsin (P01011) · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.